惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

爱范儿
爱范儿
WordPress大学
WordPress大学
C
Check Point Blog
GbyAI
GbyAI
U
Unit 42
Google DeepMind News
Google DeepMind News
B
Blog RSS Feed
Blog — PlanetScale
Blog — PlanetScale
J
Java Code Geeks
I
InfoQ
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
Hugging Face - Blog
Hugging Face - Blog
Vercel News
Vercel News
博客园 - 【当耐特】
美团技术团队
小众软件
小众软件
S
SegmentFault 最新的问题
Jina AI
Jina AI
阮一峰的网络日志
阮一峰的网络日志
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
The Cloudflare Blog
Last Week in AI
Last Week in AI
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
V
Visual Studio Blog

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Pacific Biosciences of California, Inc. (PACB) Q1 2026 Ea...
SA Transcripts · 2026-05-08 · via All Articles on Seeking Alpha

Q1: 2026-05-07 Earnings Summary

EPS of -$0.12 beats by $0.01

 | 

Revenue of

$37.18M

(0.07% Y/Y)

misses by $2.80M

Pacific Biosciences of California, Inc. (PACB) Q1 2026 Earnings Call May 7, 2026 4:30 PM EDT

Company Participants

Christian Henry - President, CEO & Director
James Gibson - CFO & Principal Accounting Officer

Conference Call Participants

Caylene Parrish
Pradeep Ambrose - TD Cowen, Research Division
Austin Kennedy - Wolfe Research, LLC
Alexandra Jane Aylen - Canaccord Genuity Group Inc.
Karan Patel - Piper Sandler & Co., Research Division
Mason Carrico - Stephens Inc., Research Division

Presentation

Operator

Welcome to the PacBio First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.

I would now like to turn the conference over to Caylene Parrish with Investor Relations. Please go ahead.

Caylene Parrish

Good afternoon, and welcome to PacBio's First Quarter 2026 Earnings Conference Call. Earlier today, we issued a press release outlining the financial results we'll be discussing on today's call, a copy of which is available on the Investors section of our website at www.pacb.com, or as furnished on Form 8-K available on the Securities and Exchange Commission website at www.sec.gov. A copy of our earnings presentation is also available on the Investors section of our website.

With me today are Christian Henry, President and Chief Executive Officer; and Jim Gibson, Chief Financial Officer.

On today's call, we will make forward-looking statements, including, among others, statements providing predictions, estimates, expectations and guidance. You should not place undue reliance on forward-looking statements because they are subject to assumptions, risks and uncertainties that could cause our actual results to differ materially from those projected or discussed. Please review our SEC filings, including our most recent Form 10-Q and 10-K and our press releases to better understand the risks and uncertainties that could cause results to differ. We disclaim any obligation to update or revise these forward-looking statements, except as required by law. We also present certain financial information on a non-GAAP basis, which is